60results about How to "No toxic side effects were found" patented technology

The invention discloses a medicament for treating liver disease, which is prepared from the following medicines in parts by weight: 1 part of radix bupleuri, 4 parts of Arundina graminifolia, 1.25 parts of mahoniae, 2.25 parts of medlar, 1.75 parts of fruit of Chinese magnoliavine, 1.25 parts of radix Salviae Miltiorrhizae, 3.5 parts of hawkthorn, 2.5 parts of areca and 0.5 part of liquorice; the medicament for treating liver disease has the functions of strengthening spleen, soothing liver, promoting blood circulation, stopping pain, protecting liver and benefiting gallbladder, and is used for treating liver and gallbladder dysfunction and liver-gallbladder diseases, such as hepatitis A / B, fatty liver, alcoholic liver, liver cancer, cholecystitis, cholelithiasis and the like, caused by abnormality of bile and toxicant excretion.

The invention relates to a traditional Chinese medicinal composition for curing hyperuricacidemia, gout and urinary retention. The traditional Chinese medicinal composition comprises fruit of austral akebia, Digua fig stem, China fir and weeping willow, and specific ingredients and dosage of a prescription are modified according to symptoms of patients. The composition is capable of fully utilizing traditional Chinese medicinal resources, reducing cost, improving curative effects, clearing heat, promoting diuresis, promoting blood circulation to arrest pain, promoting urination, obviously reducing blood uric acid levels of patients to the range of normal values, and markedly eliminating gout symptoms in different parts of patient bodies. Besides, the traditional Chinese medicinal composition can be taken for a long term without any toxic and side effects and has a certain preventive effect on the hyperuricacidemia and the gout.

The invention discloses a traditional Chinese medicine composition formula for treating calculosis, composed of desmodium, digua fig stem and leaf, lygodium japonicum, China fir, tuckahoe, corn silk, weeping willow and fringed pink. The pharmaceutical composition has the effects on clearing away heat, promoting diuresis, promoting blood circulation, relieving pain, removing calculus and inducing diuresis, can be used for treating different sizes of calculuses in hepatic ducts, parotid gland, lacrimal gland, bile ducts and gall bladder and urethral calculus in kidney, nephric ducts, bladder and the like, also can be used for treating calculus pain, retention of urine and other related complications, and is a relatively ideal clinical therapeutic medicament for calculosis. In addition, the medicament is not found having any toxic side effects and has certain preventive effects on all kinds of calculosis if a small dose of medicament is taken for a long time.

The invention relates to a medicament for treating mastopathy, which is prepared form the following medicinal materials in part by weight: 1 to 3 parts of Motherwort herb, 1 to 3 parts of lasianthus chinensis, 1 to 3 parts of zedoary, 1 to 3 parts of root of red-rooted salvia, 0.5 to 1 part of serrate glory-bower, 1 to 2 parts of rhizoma corydalis, 1 to 3 parts of cyperusrotundus, 1 to 3 parts of mongolian dandelion herb and 1 to 2 parts of mirabilite. The medicament adopts a formula consisting of a plurality of medicinal materials, and has the effects of activating blood and dissolving stasis, softening hardness to dissipate stagnation, and dispersing swelling and relieving pain so as to fulfill the aims of clearing fire and detoxifying, freeing vitality and activating blood, eliminating stasis and relieving pain, and dispersing swelling and dissipating stagnation when the medicinal materials are used together. The medicament is prepared into different formulations by applying modern technology for clinical use, and has obvious curative effect.

The invention relates to a medicament for treating pharyngitis, which is prepared from the following medicaments in part by weight: 1 to 3 parts of dregea sinensis, 1 to 2 parts of baical skullcap root, 1 to 2 parts of common alstonia leaf and 0.5 to 1 part of liquoric root. The medicament has reasonable compatibility, acute toxicity tests prove that the medicament has no toxic response, safe and reliable curative effects, good formulations and mouthfeel, and effects of improving local curative effect because of buccal administration, clearing heat and detoxifying, relieving sore throat and downbearing counterflow, and relieving cough and reducing sputum. The clinical curative effect observation and acute toxicity research prove that the medicament has the advantages of no toxic or side responses, and safe and reliable curative effects and is suitable for preventing and treating diseases such as acute and chronic pharyngitis, stomatitis, gingivitis, toothache due to wind-fire evil and allergic cough.

The invention discloses a Chinese herbal compound composition for treating lung diseases and a preparation method thereof. The Chinese herbal compound composition is prepared from, by weight, 3-10 parts of sun-dried ginseng, 5-16 parts of astragalus membranaceus, 4-12 parts of rhizoma chuanxiong, 1-20 parts of allium macrostemon, 12-15 parts of schisandra chinensis, 1-35 parts of semen lepidii and 15-30 parts of lumbricus. The preparation method of the Chinese herbal compound composition includes the steps of obtaining a first raw material by extracting sun-dried ginseng and astragalus membranaceus to obtain first thick paste and conducting pressure reduction band drying and smashing on the first thick paste, obtaining a second raw material by mixing decoction dregs with rhizoma chuanxiong, lumbricusm semen lepidii, schisandra chinensis and allium macrostemon to obtain second thick paste and conducting pressure reduction band drying and smashing on the second thick paste, mixing the first raw material, the second raw material and acceptable auxiliaries on pharmacy, and preparing the Chinese herbal compound composition for treating lung diseases. The Chinese herbal compound composition has the advantages that the transfer rate of astragaloside in the raw materials is high, the utilization rate of effective components in traditional Chinese medicine is high, and medical value of traditional Chinese medicine raw materials can be brought into full play.

The invention provides a medicament for treating gastric diseases. The medicament consists of the following components in part by weight: 1 to 4.5 parts of curcuma longa, 1 to 4.5 parts of zedoary, 1 to 4.5 parts of yellow ginger, 2 to 5 parts of A. maximum roxb., 1 to 5 parts of sassafras pith, 3 to 7 parts of Chinese fever vine, 1 to 3 parts of rhubarb, and 0.5 to 1.5 parts of stephania epigaea. The medicament can be used for treating gastric diseases, such as pain of the gastral cavity caused by acute and chronic gastritis, enteritis, antrum gastrititis, gastric ulcer, dyspepsia, cholecystitis, calculi and the like; and the clinical observation on curing effects and the researches on acute toxicity tests prove that the medicament does not generate toxic and side reactions, is safe and reliable and has obvious curing effect.

The invention discloses a medicament for treating femoral head ischemic necrosis, which comprises the constituents of (by weight percent) tortoise shell30-60, dragon's blood resin 40-60, antler gelatin 40-60, pangolin scales 40-60, rhizome of Sichuan lovage 40-60, Chinese angelica root 40-60, safflower 40-60, prepared rehmannia root 40-60, the traditional Chinese medicinal preparation is synthesized through screening, purification, sterilization, drying and disintegration.

The invention relates to a traditional Chinese medicine monomer compound preparation for preventing and treating diabetic heart injuries, and a preparation method thereof and belongs to the technical field of traditional Chinese medicine monomer compound preparations. According to the technical scheme, a quercetin monomer, a resveratrol monomer and an extracted powdery buckwheat rutin monomer are matched and prepared into the compound preparation; and the contentsof quercetin, resveratrol and buckwheat rutin, in percentage by mass, are 10-20%, 10-30% and 60-70% respectively. According to the compound preparation and the preparation method disclosed by the invention, raw material resources are abundant, special instrument and equipment are not needed, the cost is low, and application is convenient; by combination of the quercetin monomer with very high purity, the resveratrol monomer with a very high purity, and the rutin monomer extracted and separated from buckwheat flower leaves by a proper solvent, the multiple effects of traditional Chinese medicine are favourably exerted, the theory of traditional Chinese medicine is met, the multi-part and multi-target action mechanism of traditional Chinese medicine is embodied, and the effects are obvious and safe; and the compound preparation disclosed by the invention has a protection effect on the heart (myocardium and heart capillaries) injuries of diabetic rats, has no toxic or side effects in animal experiments, and has the characteristics of high curative effect, low dose, convenience in applicaiton and the like.

The invention relates to a medicament for treating gynecological diseases, which is prepared from the following raw material medicaments in part by weight: 5 parts of arundina graminifolia, 3.6 parts of Mongla dregea volubilis, 3.3 parts of motherwort herb, 3.5 parts of floralwhite clerodendrum bungei root, 2.7 parts of turmeric, 2.7 parts of mappianthus iodoies, 1 part of rhizoma corydalis and 1 part of yerbadetajo herba ecliptae. The medicament is developed by screening, researching, adding and subtracting Dai medicine traditional toxicides and formulas for clearing heat and detoxicating and activating blood and regulating menstruation on the basis of treatment principle of Dai medicine detoxication theory in Chinese traditional medicine. The medicament is prepared into modern formulations such as powder, capsules, tablets and granules and the like by combing the modern pharmaceutical technology on the basis of the raw decoction, and has the traditional characteristics of Dai medicine and the characteristics of modern preparations.

The invention discloses a medicinal composition for treating stroke diseases, and a preparation thereof. The medicinal composition is a pure traditional Chinese preparation prepared through using ginseng, safflower, peach seed, Radix Paeoniae Rubra and lumbricus. Tests prove that the medicinal composition has the efficacies of qi tonifying, blood circulation promoting, stasis removing and collateral dredging, and is suitable for patients suffering from stroke diseases, especially qi deficiency and blood stasis strokes.

The invention relates to a medicament for treating urinary infection and lithiasis, which is prepared from the following medicinal materials in parts by weight: 1-5 parts of aspidopterys glabriuscula, 1-3 parts of wild reed cereal roots, 1-3 parts of conical celastrus orbiculatus, 1-3 parts of folium orthosiphoni and 1-2 parts of liquorice. The medicament is used for treating acute and chronic nephritis, pyelitis, urinary tract infection, renal calculi, ureter calculi, bladder calculi and the like; the medicament prepared into different preparations by applying the modern technique is applied in clinics to obtain an obvious therapeutic effect, and the research on the main pharmacodynamics proves that the medicament has no toxic or side reaction, safe and has reliable and obvious therapeutic effect, good development and application prospect and market competitiveness through clinical therapeutic effect observation and urgent toxin test.

The invention discloses a pharmaceutical composition and its preparation containing rhizoma arisaematis for treating stroke. The pharmaceutical composition is a pure Chinese material medical preparation prepared by rhizoma arisaematis, arisaema cum bile, uncaria, bulbus fritillariae cirrhosae and concha haliotidis. The tests prove that the pharmaceutical composition has efficacy of eliminating phlegm by cooling and inducing resuscitation, and is suitable for stroke paralytics, especially for phlegm-heat inner closed paralytics.

The invention discloses a peach seed-containing medicinal composition for treating stroke diseases, and a preparation thereof. The medicinal composition is a pure traditional Chinese preparation prepared through using Chinese angelica, Radix Astragali, Radix Paeoniae Rubra, lumbricus and peach seed. Tests prove that the medicinal composition has the efficacies of qi tonifying, blood circulation promoting, stasis removing and collateral dredging, and is suitable for patients suffering from stroke diseases, especially qi deficiency and blood stasis strokes.

The invention relates to functional nutrition powder capable of reducing blood glucose, reducing fat and protecting diabetes organ as well as a preparation method and an eating method thereof, which belong to the technical field of medicinal and edible functional food. The functional nutrition powder has the components in parts by weight: 10-30 parts of fermentation sweet buckwheat flour, 5-15 parts of fried broom corn millet, 1-5 parts of a grape seed extract product, 1-3 parts of rutin, and 1-3 parts of chitosan. The functional nutrition powder has the advantages of good mouthfeel, high nutrition value, natural performance and safety, and reasonable food material matching, and embodies comprehensive conditioning effect; preparation and application are convenient, the effect is obvious, The product has obvious body weight and blood sugar reducing effects for spontaneous obesity type 2 diabetes db / db mice, and has protection effect on heart tissue organ, and no toxic side effects can be generated for animal experiments.

The invention discloses a Boswellia carteri-containing medicinal composition for treating stroke diseases, and a preparation thereof. The medicinal composition is a pure traditional Chinese preparation prepared through using Chinese angelica, Radix Astragali, Boswellia carteri, myrrh and lumbricus. Tests prove that the medicinal composition has the efficacies of qi tonifying, blood circulation promoting, stasis removing and collateral dredging, and is suitable for patients suffering from stroke diseases, especially qi deficiency and blood stasis strokes.

An externally-applied staltic Chinese medicine for battlefield rescue is prepared from 6 Chinese-medicinal materials including red halloysite, calomelas, roasted alum, rhubarb, etc.

A Chinese medicine for treating tumor and cancer is prepared from 25 Chinese-medicinal materials including fennel, ledebouriella root, white mustard seed, plantain seed, etc. Its advantages are simple preparing process and high curative effect.

The invention relates to a medicament for treating hepatopathy. The medicament is prepared from Chinese herbal medicines, in order to solve the problems of full utilization of traditional Chinese medicine resources, cost reduction and curative effect improvement. A basic formula provided by the invention comprises 8-12 parts of turquoise, 38-42 parts of processed red coral, 78-82 parts of subprostrate sophora root, 48-52 parts of isatis root, 58-62 parts of Hedyotis diffusa, 48-52 parts of Chinese violet, 38-42 parts of saxifrage, 38-42 parts of Meconopsis quintuplinervia, 38-42 parts of Artemisia vestita, 38-42 parts of Herba Aconiti Tangutici, 58-62 parts of saffron, 28-32 parts of calamus, 28-32 parts of Cortex Phellodendri, 48-52 parts of Radix Astragali, 98-102 parts of polygonatum rhizome, 48-52 parts of Chinese yam, 1.8-2.2 parts of artificial bezoar, 28-32 parts of licorice, 0.8-1.2 parts of artificial musk, 1.8-2.2 parts of artificial bear gall, 28-32 parts of white peony root, 18-22 parts of polygonatum, 38-42 parts of fructus amomi villosum, 28-32 parts of Chinese angelica and 18-22 parts of tuber of multiflower knotweed.

The invention provides a medicament for treating rheumatism, which is prepared from the following medicinal materials in part by weight: 3.6 parts of fissistigma polyanthum, 1.6 parts of cassia twig, 1 part of gambir plant, 1 part of sappan wood, 2.4 parts of common clubmoss herb, 1.2 parts of crisped tinospora stem and 3.2 parts of mappianthus iodoies. The medicament is used for treating cold and hot rheumatalgia, limp and numb swollerpain or red and swollen heat pain of body joints, muscles and bones, and has the effects of dispelling wind and activating blood, and freeing impediment and relieving pain. The medicament is prepared by applying new industrial research of modern pharmacy according to the compatibility principle of Dai medicament. The medicament is prepared into powder, capsules, tablets and granules by combing the modern pharmaceutical technology, has the traditional characteristics of Dai medicine and the characteristics of modern preparations. The clinical curative effect observation and acute toxicity test research prove that the medicament has the advantages of no toxic or side response, and safe and reliable curative effects.

The invention discloses a drug for treating cervical or lumbar diseases. The drug is composed of the following raw materials by weight: 50-70 parts of astragalus mongholicus, 15-30 parts of angelica sinensis, 20-30 parts of white atractylodes rhizome, 15-30 parts of cistanche, 15-25 parts of eucommia ulmoides, 6-18 parts of sea horse, 15-30 parts of cortex acanthopanacis, 15-30 parts of radix angelicae pubescentis, 10-15 parts of notopterygium root, 30-70 parts of herba siegesbeckiae, 20-50 parts of caulis spatholobi, 15-50 parts of caulis sinomenii, 6-20 parts of radix aconiti preparata, 6-20 parts of prepared kusnezoff monkshood root, 20-60 parts of radix clematidis, 15-30 parts of homalomena occulta, 5-8 parts of scorpion, 2-4 centipedes, 10-20 parts of earthworm, 3-8 parts of long-noded pit viper, 10-15 parts of cynanchum paniculatum, 15-30 parts of radix cyathulae, 10-24 parts of ephedra and 15-30 parts of kudzu vine root. A preparation method for the drug comprises the steps as follows: firstly, dividing part of the raw materials into two batches, soaking with water, decocting with strong fire, filtering, decocting for three times, taking juice, filtering, depositing and decocting into paste; secondly, mixing and grinding part of the raw materials, soaking in wine for 5 days, filtering, and taking liquid medicine for later use; thirdly, drying, grinding and sieving part of the raw materials; and finally, preparing into pills. The drug integrates the functions of tonifying vital energy and nourishing blood, nourishing liver and kidney, clearing and activating channels and collaterals, dispelling wind and removing moisture, warming Yang and dredging collaterals; and 618 clinical patients prove that the total efficiency is 97.9% and the healing rate is 80.4%.

The invention relates to a medicament for treating diabetes, which is prepared from the following medicinal materials in part by weight: 1 to 10 parts of ladybell root, 1 to 4 parts of dwarf lilyturf tuber, 1 to 3 parts of asparagus, 1 to 3 parts of dendrobium, 1 to 2.5 parts of mongolian snakegourd root, 1 to 3 parts of kudzu-vine root, 1 to 7 parts of arundina graminifolia, and 1 to 2.5 parts of mahonia fortunei. The medicament is used for treating polydipsia, polyphagia, polyuria, emaciation and weakness caused by the diabetes. Clinical use, acute toxicity research and clinical curative effect observation prove that the medicament has obvious curative effect, no toxic or side response, and the effects of protecting organs, reducing blood sugar, improving clinical diseases and the like.

The invention discloses a pharmaceutical composition and its preparation containing polygala tenuifolia for treating stroke. The pharmaceutical composition is a pure Chinese material medical preparation prepared by polygala tenuifolia, rhizoma acori graminei, calculus bovis, musk, bamboo juice and uncaria rhynchophylla. The tests prove that the pharmaceutical composition has efficacy of eliminating phlegm by cooling and inducing resuscitation, and is suitable for stroke paralytics, especially for phlegm-heat inner closed paralytics.

The invention discloses a medicament for treating kidney, nephric duct and bladder stone, and belongs to the technical field of traditional Chinese medicine. The medicament is prepared from the following raw materials in parts by weight: 15 to 25 parts of spora lygodii, 15 to 25 parts of endothelium corneum gigeriae galli, 15 to 25 parts of walnut kernel, 15 to 20 parts of brown sugar, 15 to 25 parts of bee wax and 8 to 10 parts of fossil grass. The medicament for treating kidney, nephric duct and bladder stone is safe and reliable, does not cause pain to patients, is convenient to make, is easy to store, and has the effects of nourishing kidney and dissolving kidney stone. The medicament is prepared into different dosage forms by a modern technology, and has a remarkable curative effect in clinical application. As proved by clinical curative effective observation and acute toxicity test researches, the medicament has the advantages of no toxic and side reactions, safe and reliable curative effect, remarkable curative effect, very good development and application prospects and market competitiveness.

The invention relates to a traditional Chinese medicine composition used for secondary prevention of acute coronary syndrome after PCI. 1.3 parts, 10 parts of Danshen, 4 parts of Yinhua. The present invention also includes the application of the traditional Chinese medicine composition in the preparation of secondary prevention medicine for acute coronary syndrome after PCI. In the prescription, the fairy spirit spleen warms and invigorates the innate kidney essence as the monarch drug; Radix Pseudostellariae tonifies the heart qi, and helps the monarch medicine to strengthen the effect as the minister drug; leech and salvia miltiorrhiza reduce phlegm and blood stasis to dredge the heart collaterals, and honeysuckle clears heat and detoxifies as the adjuvant drug , the whole prescription treats the heart and kidney at the same time, mainly tonifying, taking tonifying as the way, tonifying and tonifying, tonifying but not obstructed, and tonifying without damage. It has the effects of warming the kidney yang, nourishing the heart, eliminating phlegm and blood stasis, and dredging the heart and collaterals . The experimental results show that this formula is used for this type of patients, has good curative effect, no toxic and side effects, and has broad application prospects.

The invention relates to a medicament for treating gynecological diseases, which is prepared from the following raw material medicaments in part by weight: 5 parts of arundina graminifolia, 3.6 parts of Mongla dregea volubilis, 3.3 parts of motherwort herb, 3.5 parts of floralwhite clerodendrum bungei root, 2.7 parts of turmeric, 2.7 parts of mappianthus iodoies, 1 part of rhizoma corydalis and 1part of yerbadetajo herba ecliptae. The medicament is developed by screening, researching, adding and subtracting Dai medicine traditional toxicides and formulas for clearing heat and detoxicating and activating blood and regulating menstruation on the basis of treatment principle of Dai medicine detoxication theory in Chinese traditional medicine. The medicament is prepared into modern formulations such as powder, capsules, tablets and granules and the like by combing the modern pharmaceutical technology on the basis of the raw decoction, and has the traditional characteristics of Dai medicine and the characteristics of modern preparations.

The invention relates to a medicament for treating diabetes, which is prepared from the following medicinal materials in part by weight: 1 to 10 parts of ladybell root, 1 to 4 parts of dwarf lilyturf tuber, 1 to 3 parts of asparagus, 1 to 3 parts of dendrobium, 1 to 2.5 parts of mongolian snakegourd root, 1 to 3 parts of kudzu-vine root, 1 to 7 parts of arundina graminifolia, and 1 to 2.5 parts of mahonia fortunei. The medicament is used for treating polydipsia, polyphagia, polyuria, emaciation and weakness caused by the diabetes. Clinical use, acute toxicity research and clinical curative effect observation prove that the medicament has obvious curative effect, no toxic or side response, and the effects of protecting organs, reducing blood sugar, improving clinical diseases and the like.